E136: Secukinumab in PMR (REPLENISH)
About this episode
This episode discusses a significant trial on secukinumab for PMR and its implications for FDA approval.
Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I would bet on FDA approval in the near future. Some interesting tidbits and of course a weird safety thing we now have to grapple with. Be sure to go to boardsbank.com! Free rheumatology board review, >1000 questions! Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2602567
Sponsors
boardsbank.com
More episodes of The Evidence Based Rheumatology Podcast
Explore listener stats, chart rankings, contacts and more on the The Evidence Based Rheumatology Podcast podcast page.